Diarrhea News and Research

Latest Diarrhea News and Research

HIV-positive women in the United States face strikingly high levels of stigma

HIV-positive women in the United States face strikingly high levels of stigma, according to survey results released today by amfAR, The Foundation for AIDS Research.

1 Apr 2008

Eli Lilly starts trial of treatment of mild to moderate Alzheimer's disease

Eli Lilly and Company has announced the start of a Phase III clinical trial studying LY450139, an investigational gamma secretase inhibitor for the treatment of mild to moderate Alzheimer's disease.

1 Apr 2008

Human vaccine for Ebola in the pipeline

The deadly Ebola virus is in the news again but this time there is the promise of a vaccine for the deadly disease.

1 Apr 2008

Naglazyme approved in Japan

BioMarin Pharmaceutical Inc. has announced that AnGes MG, Inc. (AnGes), BioMarin's marketing and distribution partner in Japan, has received approval for its Marketing Application for Naglazyme(R) (galsulfase) from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with Mucopolysaccharidosis VI ( MPS VI).

1 Apr 2008

Ebola virus vaccines for humans

One of the world's deadliest diseases, caused by the Ebola virus, may finally be preventable thanks to US and Canadian researchers, who have successfully tested several Ebola vaccines in primates and are now looking to adapt them for human use.

31 Mar 2008

FDA issues Salmonella Litchfield alert for cantaloupe from Agropecuaria Montelibano

The U.S. Food and Drug Administration has issued an import alert regarding entry of cantaloupe from Agropecuaria Montelibano, a Honduran grower and packer, because, based on current information, fruit from this company appears to be associated with a Salmonella Litchfield outbreak in the United States and Canada.

28 Mar 2008

Scientists discover how salmonella becomes lethal for AIDS patients

Nearly half of all HIV-positive African adults who become infected with Salmonella die from what otherwise would be a seven-day bout of diarrhea.

25 Mar 2008

Sanitation investment in poor countries would yield $9-to-1 benefits in productivity, health and other benefits

Experts estimate that $9 in productivity, health and other benefits are returned for every dollar invested installing toilets for people in countries that today are off-track in meeting the UN Millennium Development Goal (MDG) for sanitation.

24 Mar 2008

Sixty-two per cent of Africans do not have access to a proper toilet

Sixty-two per cent of Africans do not have access to an improved sanitation facility -- a proper toilet -- which separates human waste from human contact, according to the WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation.

24 Mar 2008

A national Clostridium difficile prevalence study

The Association for Professionals in Infection Control and Epidemiology (APIC) has announced a detailed strategy to combat Clostridium difficile-associated disease (CDAD).

24 Mar 2008

New understanding of Norwalk virus

Using the Canadian Light Source synchrotron, an international team led by University of Calgary researcher Ken Ng has determined the detailed structure of the enzyme the Norwalk virus uses to make copies of its genetic code in order to replicate itself.

20 Mar 2008

Experts warn, no Easter chocolate for pets!

Experts are warning pet owners not to give their dogs or cats chocolate over the Easter period.

19 Mar 2008

Scientists identify potential therapy targets for schistosomiasis

A research team supported by the National Institutes of Health (NIH) Roadmap and the National Institute of Allergy and Infectious Diseases (NIAID) has identified chemical compounds that hold promise as potential therapies for schistosomiasis, a parasitic disease that afflicts more than 200 million people worldwide.

18 Mar 2008

NanoBio successfully completes phase 2b study in Herpes labialis

NanoBio Corporation reported top-level findings from its phase 2b study of NB-001, a topical lotion to treat herpes labialis (cold sores).

18 Mar 2008

Discovery of chemical compounds that hold promise as potential therapies for schistosomiasis

17 Mar 2008

Caspase-12: MUHC researcher finds new defense mechanism against intestinal inflammation

The body's first line of defence against pathogenic bacteria that we ingest may not be the immune system but rather the cells that line the intestine.

13 Mar 2008

Anadis licenses antibody technologies from ImmuCell

Anadis Limited, an Australian-based biotechnology company focused on milk derived polyclonal antibodies and other milk-derived bioactives, announced today that it had signed a final agreement with ImmuCell Corporation, a biotechnology company headquartered in Portland, Maine, USA.

11 Mar 2008

Scientists unlock secrets of E coli contamination

Using new genetic techniques, scientists are unlocking the secrets of how E coli bacteria contaminate food and make people sick.

11 Mar 2008

Real-time imaging device may improve surgery for congenital colon disease

Researchers at Cedars-Sinai Medical Center are developing a spectral imaging system that could result in shorter operating times for infants undergoing surgery for Hirschsprung's disease, according to a mouse study reported in the Journal of Biophotonics.

1 Mar 2008

FDA approves Nexium for gastroesophageal reflux disease in children

The U.S. Food and Drug Administration approved Nexium (esomeprazole magnesium) for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease (GERD).

28 Feb 2008